H2-receptors in the human ocular surface

Archives of Ophthalmology

Volumn 99, Issue 2, 1981, Pages 302-304

  Abelson, Mark B ^a   Udell, Ira J ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAZOLINE; CIMETIDINE; DIMAPRIT; HISTAMINE H2 RECEPTOR; HISTAMINE RECEPTOR; THIOUREA;

ARTICLE; CONJUNCTIVA; DRUG EFFECT; HUMAN; HYPEREMIA; IATROGENIC DISEASE; VASCULARIZATION; VASODILATATION; EYE; HUMAN CELL; NORMAL HUMAN; PHARMACOKINETICS; TOPICAL DRUG ADMINISTRATION; VISUAL SYSTEM;

ANTAZOLINE; CIMETIDINE; CONJUNCTIVA; DIMAPRIT; HUMAN; HYPEREMIA; RECEPTORS, HISTAMINE; RECEPTORS, HISTAMINE H2; SUPPORT, NON-U.S. GOV'T; THIOUREA; VASODILATION;

EID: 0019391781     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1981.03930010304018     Document Type: Article

References (19)

1. Ash ASF, Schild HO: Receptors mediating some actions of histamine. Br J Pharmacol Chemother 27:427–439, 1966.
2. Black JW, Duncan WAM, Durant CJ, et al: Definition and antagonism of histamine H2 receptors. Nature 236:385–390, 1972.
3. Kaliner M, Austen KF: Immunologic release of chemical mediators from human tissues. Annu Rev Pharmacol 15:177–189, 1975.
4. Parsons ME, Owens DAA, Ganellin CR, et al: Dimaprit-(S-[3-(N,N-dimethylamino)prophl]isothiourea): A highly specific histamine H2-receptor agonist: I. Pharmacology. Agents Actions 7:31–37, 1977.
5. Durant GJ, Ganellin CR, Parsons ME: Dimaprit-(S-[3-(N,N-dimethylamino)propyl]isothiourea): A highly specific histamine H2-receptor agonist: II. Structure-activity considerations. Agents Actions 7:39–43, 1977.
6. Black JW, Duncan WAM, Emmett JC, et al: Metiamide: An orally active histamine H2-receptor antagonist. Agents Actions 3:133–137, 1973.
7. Brimblecoombe RW, Duncan WAM, Durant GJ, et al: Cimetidine: A non-thiourea H2-receptor antagonist. J Int Med Res 3:86–92, 1975.
8. Blackwood WS, Maudgal DP, Pickard RG, et al: Cimetidine in duodenal ulcer: Controlled trial. Lancet 11:174–176, 1976.
9. Brimblecoombe RW, Duncan WAM, Durant GJ, et al: Characterization and development of cimetidine as a histamine H2-receptor antagonist. Gastroenterology 74:339–347, 1978.
10. Beaven MA: Histamine. N Engl J Med 294:320–325, 1976.
11. Douglas WW: Histamine and antihistamines; 5-hydroxytryptamine and antagonists, in Goodman LS, Gilman A (eds): The Pharmacologie Basis of Therapeutics. New York, Macmillan Publishing Co Inc, 1975, vol 29, p 609.
12. Chand N, Eyre P: Classification and biological distribution of histamine receptor subtypes. Agents Actions 5:277–295, 1975.
13. Powell JR, Brody MJ: Identification and specific blockade of two receptors for histamine in the cardiovascular system. J Pharmacol Exp Ther 196:1–14, 1976.
14. Marks R, Greaves MW: Vascular reactions to histamine and compound 48/80 in human skin: Suppression by a histamine H2-receptor blocking agent. Br J Clin Pharmacol 4:367–369, 1977.
15. Brimblecoombe RW, Duncan WAM, Owen DAA, et al: The pharmacology of burimamide and metiamide, two histamine H2-receptor antagonists. Fed Proc Fed Am Soc Exp Biol 35:1931–1934, 1976.
16. Lichtenstein LM: Hormone receptor modulation of cAMP in the control of allergic and inflammatory responses, in Beers RF Jr, Bassett EG (eds): The Role of Immunologic Factors in Infectious, Allergic and Autoimmune Processes. New York, Raven Press, 1976, pp 339–354.
17. Abelson MB, Soter NA, Simon MA, et al: Histamine in human tears. Am J Ophthalmol 83:417–418, 1977.
18. Keele CA, Armstrong D: Histamine, in Substances Producing Pain and Itch. Baltimore, Williams & Wilkins Co, 1964, chap 8, pp 124–151.
19. Abelson MB, Allansmith MR: Histamine and the eye, in Silverstein A, O'Connor G (eds): Immunology and Immunopathology of the Eye. New York, Masson Publishing, 1979, vol 65, pp 362–364.